AstraZeneca shares fell nearly 3% as its third-quarter earnings missed expectations

Tiger Newspress2021-11-12

AstraZeneca shares fell nearly 3% in premarket trading.Total revenue jumped 47% to $9.74 billion for the three months to September on a constant-currency basis, while core earnings came in at $1.08 per share, the company said.

Analysts on average were expecting profit of $1.28 per share on sales of $9.4 billion, according to Refinitiv IBES data.

免责声明:本文观点仅代表作者个人观点,不构成本平台的投资建议,本平台不对文章信息准确性、完整性和及时性做出任何保证,亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

  • Trainman
    2021-11-13
    Trainman
    Mostlt used in Japan and Taiwan.
  • Kel9670ong
    2021-11-12
    Kel9670ong
    Well, as more countries have achieved high vaccination rate the demand thus fall. It's therefore important for phrama to look beyond relying on covid vaccine
  • MoonMoon
    2021-11-12
    MoonMoon
    Like
  • MHh
    2021-11-12
    MHh
    Oops… due to poor vaccine sales? Not the most optimal benefit compared to side effects…
    • MHh
      I wouldnt want the vaccine too haha
    • MFME
      yeah
  • HeroSmurf
    2021-11-12
    HeroSmurf
    Gg
  • angskk
    2021-11-12
    angskk
    Pls like thks
发表看法
10